Cognitive Behavioral and Faith Fellowship to Improve Thy Health

Description

Investigators will examine the efficacy of a faith-based depression intervention, in reducing symptoms of depression among African American adults in Wisconsin. Twelve church groups, each with 10 people (N=120) will be invited to participate. This intervention will be the first evidence-based, faith-based intervention designed for African Americans if validated.

Conditions

Depression

Study Overview

Study Details

Study overview

Investigators will examine the efficacy of a faith-based depression intervention, in reducing symptoms of depression among African American adults in Wisconsin. Twelve church groups, each with 10 people (N=120) will be invited to participate. This intervention will be the first evidence-based, faith-based intervention designed for African Americans if validated.

Cognitive Behavioral and Faith Fellowship to Improve Thy Health (CB-FAITH) - a Feasibility and Acceptability Study

Cognitive Behavioral and Faith Fellowship to Improve Thy Health

Condition
Depression
Intervention / Treatment

-

Contacts and Locations

Madison

Second Baptist Church, Madison, Wisconsin, United States, 53711-3800

Madison

The Board of Regents of the UW System, Madison, Wisconsin, United States, 53715-1218

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * self-identify as an African American man or woman
  • * are ages 18 and older
  • * have symptoms of major depressive disorder, as evidenced by score of 10 and higher from the Patient Health Questionnaire-9 (PHQ-9).
  • * major psychotic illnesses, such as schizophrenia;
  • * current participation in psychotherapy
  • * current suicidal ideations (trained staff will conduct a suicide risk assessment and facilitate referral for appropriate care).
  • * Medication stabilization. Eligible participants who report recent changes to their psychiatric medications (i.e., initiation of a new medication, change in dose or type of medication) will delay their study enrollment for a stabilization period of 4 weeks. Baseline data collection will be re-administered
  • * alcohol or drug dependence - those with alcohol or other drug dependence who have been clean and sober for 3 months will not be excluded

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Wisconsin, Madison,

Earlise Ward, PhD, PRINCIPAL_INVESTIGATOR, University of Wisconsin, Madison

Study Record Dates

2026-09